eli lily retatrutide is Lilly’s “Triple G”, A novel triple agonist for GIP, GLP1, and glucagon receptors., A 48 week phase 2 obesity study demonstrated 24.2% weight loss with retatrutide 12 mg with no Lilly's Retatrutide Continues To Show

They can also help you decide whether semaglutide is the right fit or if it may be beneficial to switch to another type of weight loss medication that your body may tolerate better

Dickson et al., 2012), and hindbrain (Hayes et al., 2011

Three Receptors Targets GLP-1, GIP, and glucagon receptors

Research shows that continuing GLP-1 therapy helps sustain weight loss and reduces the risk of regaining weight

So, the route of administration matters

Now back on Lymecycline so I think I may try see if there is alternative b12 options such as tablets minniemouse89, I have to confess I haven't read every post on this thread, so apologies if I'm saying something that's already been said